Jessica J. Lie

Jessica J. Lie

Auto-generated profile, based on publicly available information

Jessica J. Lie

Department of Surgery, University of British Columbia, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Surgical Education
Verified
Journal Article
Closed access
JLJessica J. Lie
Jessica J. Lie
CHCaroline Huynh
Caroline Huynh
TSTracy M. Scott
Tracy M. Scott
AKAhmer Azhar Karimuddin
Ahmer Azhar Karimuddin

11 March 2023 in The American Journal of Surgery
Verified
Journal Article
Closed access
JLJessica J. Lie
Jessica J. Lie
KNKylie Nabata
Kylie Nabata
JZJenny W. Zhang
Jenny W. Zhang
DZDarren Zhao
Darren Zhao
CPChan Mi Park
Chan Mi Park
THTrevor Hamilton
Trevor Hamilton

23 February 2023 in Colorectal Disease
Verified
Journal Article
Closed access
JLJessica J. Lie
Jessica J. Lie
HYHyea Min Yoon
Hyea Min Yoon
AKAhmer A. Karimuddin
Ahmer A. Karimuddin
MRManoj J. Raval
Manoj J. Raval
PPP. Terry Phang
P. Terry Phang
CBCarl J. Brown
Carl J. Brown

25 July 2024 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
JLJessica J. Lie
Jessica J. Lie
NSNadeesha Samarasinghe
Nadeesha Samarasinghe
AKAhmer A. Karimuddin
Ahmer A. Karimuddin
CBCarl J. Brown
Carl J. Brown
PPP. Terry Phang
P. Terry Phang
AGAmandeep Ghuman
Amandeep Ghuman

22 February 2024 in Journal of Surgical Education
Verified
Journal Article
Closed access
JLJessica J. Lie
Jessica J. Lie
CHCaroline Huynh
Caroline Huynh
JLJennifer Li
Jennifer Li
NMNicole Mak
Nicole Mak
SWSam M Wiseman
Sam M Wiseman

17 June 2026 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
TMTeppei Miyakawa
Teppei Miyakawa
JLJessica J Lie
Jessica J Lie
CHChung-Yuan Hu
Chung-Yuan Hu
KPKentaro Ochiai, MD, PhD
Kentaro Ochiai, MD, PhD
RBRamy S Behman
Ramy S Behman
GCGeorge J Chang
George J Chang
PURPOSE: The TNM classification at pathological evaluation determines prognosis following cancer treatment. For rectal cancer patients undergoing neoadjuvant therapy, whether ypTNM likely confers different prognosis than pTNM. We compared survival outcomes of patients classified by ypTNM vs pTNM staging. PATIENTS AND METHODS: Patients with resected locoregional rectal cancer from the National Cancer Database who underwent upfront surgery (pTNM) and had ≥5 years follow-up (2010 to 2017) were compared with those receiving neoadjuvant therapy followed by surgery (ypTNM). To address treatment selection bias, analyses were stratified by receipt of guideline-concordant care. Overall survival was compared using Kaplan-Meier and multivariable Cox regression analyses. RESULTS: Of 50,436 patients (median age 60; 61.4% male), 11,732 (23.3%) underwent upfront surgery and 38,704 (76.7%) received neoadjuvant therapy; 78.8% of the upfront surgery group received guideline-concordant care. In analyses stratified by guideline-concordant care, overall survival was similar for stage 0-I (hazard ratio [HR] 1.05; 95% CI 0.96-1.15) but significantly worse for ypTNM vs pTNM in stage II (HR 1.50; 95% CI 1.27-1.77; 5-year OS 75.6% vs 83.2%) and stage III (HR 1.60; 95% CI 1.46-1.75; 5-year OS 67.0% vs 78.2%). Multivariable analysis confirmed ypTNM was associated with worse survival at each stage (stage 0-HR 1.14, P=.004; stage II: HR 1.49, P<.001; stage III: HR 1.60, P<.001). CONCLUSION: Stage for stage, ypTNM classification is associated with worse survival than pTNM classification, with increasing difference at higher stages. Future staging systems and management guidelines should account for these differences to optimize prognostication and stratification for clinical trials and surveillance strategies.